Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature Two case reports4900 Published on 2020-08-282022-10-30 Journal: Medicine [Category] COVID-19, MERS, [키워드] adverse effects antiviral drugs Case report caused Characteristics chest X-ray Clinical course Computed tomography condition consolidation coronavirus disease Coronavirus disease 2019 Corticosteroids COVID-19 develop diagnosed disease disease course hospital linear lung Mild MONITOR Organizing pneumonia patients with COVID-19 physician Pneumonia progression pulmonary fibrosis reduction regions respiratory symptom respond reversed subpleural systemic corticosteroids traction bronchiectasis treated Treatment Volume [DOI] 10.1097/MD.0000000000021804 PMC 바로가기 [Article Type] 4900
Pharmacogenomics of COVID-19 therapiesReview Article Published on 2020-08-182022-10-04 Journal: NPJ Genomic Medicine [Category] 바이오마커, 유전자 메커니즘, 임상, 치료제, [키워드] ABCC2 adverse effects Alter association Baricitinib Chloroquine clinical Concentration coronavirus disease Corticosteroids COVID-19 COVID-19 patient CYP2C8 CYP2D6 drug Effect Efficacy Efficacy and safety Evidence Favipiravir FDA food genetic marker Genetic markers genetic variants global pandemic Hemolysis high mortality Hydroxychloroquine hydroxychloroquine/chloroquine information inhibitors interferon Interferon beta-1b labeling liver morbidity notable other variants pharmacogenetics pharmacogenomics QT prolongation Remdesivir ribavirin risk ruxolitinib searched SLC28A2 SLC29A1 SLCO1A2 SLCO1B1 Therapies therapy Tocilizumab Toxicity variant viral infection website [DOI] 10.1038/s41525-020-00143-y PMC 바로가기 [Article Type] Review Article
IV artesunate for severe malariaArticle Published on 2020-08-102024-08-28 Journal: Med Lett Drugs Ther [Category] 말라리아, [키워드] adverse effects Artemether artemether-lumefantrine artesunate atovaquone/proguanil Chloroquine Clindamycin Coartem dosage doxycycline Drug interactions Efficacy Krintafel lactation malaria malarone mefloquine Pregnancy primaquine Quinine Safety tafenoquine Tetracycline
Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19 A protocol for systematic review and meta-analysis4900 Published on 2020-08-072022-10-30 Journal: Medicine [Category] COVID-19, [키워드] acute respiratory syndrome adverse effects antiplatelet/anticoagulant caused CBM clinical trial registry clinician CNKI conducted coronavirus COVID-19 COVID-19 patient data extraction database event events Evidence global pandemic identify incidence include limitation management Meta-analysis observational study outcome Patient performed Prophylactic Prophylaxis protocol Randomized control trials reliability researchers retrospective Risk of bias second sensitivity analysis severe COVID-19 severe COVID-19 patients severity statistical analysis subgroup analysis systematic review therapy Thromboembolism thrombosis Treatment trials Venous Thromboembolism Web of Science World Health Organization [DOI] 10.1097/MD.0000000000021380 PMC 바로가기 [Article Type] 4900
JAK Inhibitors Safety in Ulcerative Colitis: Practical ImplicationsJAK 억제제의 궤양성 대장염 안전성: 실용적 함의Review Published on 2020-08-012023-06-01 Journal: Journal of Crohn's & colitis [Category] 대상포진, 두창, 수두, 홍역, [키워드] adverse effects clinical care Drug safety inflammatory bowel diseases jak inhibitors monitoring preventive Tofacitinib ulcerative colitis [DOI] 10.1093/ecco-jcc/jjaa017 PMC 바로가기 [Article Type] Review
Therapeutic response to corticosteroids in a critically ill patient with COVID-19 A case report4900 Published on 2020-07-312022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] adverse effects Case report characterized Chest computed tomography consolidation consolidations coronavirus disease Corticosteroid Corticosteroids corticosteroids use COVID-19 Critically ill Critically ill patient critically ill patients Day Diagnosis discharged dose Dyspnea ENhance Hospitalization intravenous lung moderate nasal outbreak Oxygen therapy Patient patient with COVID-19 polymerase chain poor oxygenation reverse transcription SARS-CoV-2 SARS-CoV2 suffered the patient therapeutic response treated use of corticosteroid with COVID-19 worsening Wuhan [DOI] 10.1097/MD.0000000000021597 PMC 바로가기 [Article Type] 4900
COvid MEdicaTion (COMET) study: protocol for a cohort studyCOvid MEdicaTion(COMET) 연구: 코호트 연구를 위한 프로토콜Observational Study Published on 2020-07-252022-09-10 Journal: European Journal of Hospital Pharmacy [Category] 비임상, [키워드] ACE inhibitor ACE inhibitors ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted adverse effects age Angiotensin II ARB ARBs binding blocker breath cardiovascular disease circulating clinical evidence Clinical outcome clinical outcomes clinical pharmacy cohort study collected coronavirus COVID-19 database diabetes Digitalis drug Europe Evidence facilitate hospital hypertension Invasion media patients with COVID-19 protocol randomised controlled trial Randomised controlled trials receptor Receptor Blockers respiratory SARS-CoV-2 SARS-CoV-2 cell severe acute respiratory syndrome Coronavirus Sex Spike protein therapeutic strategy vascular medicine Viral viral spike protein Virology [DOI] 10.1136/ejhpharm-2020-002329 PMC 바로가기 [Article Type] Observational Study
The efficacy of acupuncture for improving the side effects of COVID-19 western medicine treatments A protocol for a systematic review and meta-analysis3800 Published on 2020-07-102022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] activated acupuncture adverse effects adverse event age alanine aminotransferase Aspartate aminotransferase blood pressure C-reactive protein CBM Chinese clinical observation clinical symptom Clinical symptoms CNKI Cochrane Library Controlled trial Coronavirus disease 2019 cough COVID-19 CRP database diagnosed with COVID-19 diarrhea disease stage Effectiveness Efficacy evaluate Evidence fatigue Fever Follow-up Handbook high mortality identify immune regulation include Infrastructure kidney literature liver liver enzyme medication Meta-analysis mortality rate myalgia nausea neuroendocrine outcome pandemic Patient patients with COVID-19 physical problems PROSPERO database protocol randomization receiving respiratory infectious disease review searched secondary serum cytokine levels Sex Side effect skin rash systematic review treat Treatment used to evaluate vomiting Western medicine [DOI] 10.1097/MD.0000000000021185 PMC 바로가기 [Article Type] 3800
SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological ScreeningReview Published on 2020-07-022022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] activity acute respiratory syndrome addition ADME adverse effects Analysis antiviral agent antiviral drug approved approved drug Chemical Chloroquine clinical impact Clinical studies clinical trials compassionate use complications convalescent plasma coronavirus diagnostic distribution drug effective effort genomic group highlighting Hydroxychloroquine Lopinavir/ritonavir management mechanism metabolism novel pandemic Perspective pharmacological public health Remdesivir SARS-CoV-2 SARS-COV-2 infection Screening These data Vaccine viral infection Viral transmission was recorded [DOI] 10.3390/jcm9072084 PMC 바로가기 [Article Type] Review
Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseasesResearch article Published on 2020-07-012022-10-05 Journal: Diabetes & metabolic syndrome [Category] SARS, 치료법, [키워드] ACE2 adverse effects affected collected convalescent plasma country COVID COVID-19 COVID-19 patient critical COVID-19 patient diabete diabetes Elsevier Francis globe Google infected individual Infection liver Liver disease liver diseases liver dysfunction Nature Neutralizing antibodies Occurrence pandemic Patient plasma protocol randomised clinical trial recovered patient Result risk SARS-CoV-2 SARS-COV-2 infection specific treatment symptomatic Taylor therapy treat Treatment Treatment protocol underlying disease viral disease viral infection WHO guidelines [DOI] 10.1016/j.dsx.2020.05.023 [Article Type] Research article